HomeBusinessHealthcare Industry Stock NewsElanco CEO On $1.7B Market For Canine Dermatology

Elanco CEO On $1.7B Market For Canine Dermatology

“The #1 reason people take their dogs to the vet is itching,” says Jeffrey Simmons, CEO of Elanco Animal Health, discussing Zenrelia’s FDA approval. Zenrelia is a once-daily oral medication that treats some allergic & dermatological conditions in dogs. He also discusses medication affordability for pets.

Morning Trade Live

30 Sep 2024

SHARE

ON AIR
11:00 am
Fast Market
12:00 am
Trading 360
REPLAY
1:00 am
Fast Market
REPLAY
2:00 am
Gamma On
REPLAY
2:30 am
Gamma On
REPLAY
3:00 am
Gamma On
REPLAY
3:30 am
Gamma On
REPLAY
education
4:30 am
Inside the Mind of a Trader
REPLAY
education
5:00 am
Inside the Mind of a Trader
REPLAY
education
5:30 am
Inside the Mind of a Trader
REPLAY
6:00 am
Gamma On
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
ON AIR
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
7:00 pm
Gamma On
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market Overtime
REPLAY
9:00 pm
Gamma On
REPLAY
education
10:00 pm
Inside the Mind of a Trader
REPLAY
education
10:30 pm
Inside the Mind of a Trader
REPLAY
education
11:00 pm
Inside the Mind of a Trader
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor